XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 6,083,000 $ 19,439,000
Short-term investments 12,821,000 0
Prepaid expenses and other current assets 390,000 389,000
Total current assets 19,294,000 19,828,000
Other assets 5,000 8,000
Total assets 19,299,000 19,836,000
Current liabilities:    
Accounts payable, accrued expenses and other 493,000 589,000
Total current liabilities 493,000 589,000
Total liabilities 493,000 589,000
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.01 par value: 10,000 shares authorized at September 30, 2023 and December 31, 2022; no shares issued or outstanding at September 30, 2023 or December 31, 2022
Common stock, $0.01 par value: 30,000 shares authorized at September 30, 2023 and December 31, 2022; 14,321 and 14,215 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 1,343,000 1,342,000
Additional paid-in capital 566,040,000 565,541,000
Accumulated deficit (548,577,000) (547,636,000)
Total stockholders’ equity 18,806,000 19,247,000
Total liabilities and stockholders’ equity $ 19,299,000 $ 19,836,000